Abstract
The postnatal development of the human hippocampal formation establishes the time and place at which we start autobiographical memories. However, data concerning the maturation of the neurochemical phenotypes characteristic of interneurons in the human hippocampus are scarce. We have studied the perinatal and postnatal changes of the dentate gyrus (DG) interneuron populations at three rostrocaudal levels. Immunohistochemically identified neurons and fibers for somatostatin (SOM-12 and SOM-28) and neuropeptide Y (NPY) and the co-localization of SOM-28 and NPY were analyzed. In total, 13 cases were investigated from late pregnancy (1 case), perinatal period (6 cases), first year (1 case), early infancy (3 cases), and late infancy (2 cases). Overall, the pattern of distribution of these peptides in the DG was similar to that of the adult. The distribution of cells was charted, and the cell density (number of positive cells/mm2) was calculated. The highest density corresponded to the polymorphic cell layer and was higher at pre- and perinatal periods. At increasing ages, neuron density modifications revealed a decrease from 5 postnatal months onward. In contrast, by late infancy, two immunoreactive bands for SOM-28 and NPY in the molecular layer were much better defined. Double-immunohistochemistry showed that NPY-positive neurons co-localized with SOM-28, whereas some fibers contained only one or other of the neuropeptides. Thus, this peptidergic population, presumably inhibitory, probably has a role in DG maturation and its subsequent functional activity in memory processing.
Similar content being viewed by others
Abbreviations
- CA1:
-
Ammonic hippocampal field 1
- CA2:
-
Ammonic hippocampal field 2
- CA3:
-
Ammonic hippocampal field 3
- DG:
-
Dentate gyrus
- GW:
-
Gestational weeks
- HF:
-
Hippocampal formation
- LTP:
-
Long term potentiation
- NPY:
-
Neuropeptide Y
- SOM-12:
-
Somatostatin (1–12)
- SOM-28:
-
Somatostatin 28
References
Abraham H, Veszpremi B, Gomori E, Kovacs K, Kravjak A, Seress L (2007) Unaltered development of the archi- and neocortex in prematurely born infants: genetic control dominates in proliferation, differentiation and maturation of cortical neurons. Prog Brain Res 164:3–22
Allen JM, McGregor GP, Woodhams PL, Polak JM, Bloom SR (1984) Ontogeny of a novel peptide, neuropeptide Y (NPY) in rat brain. Brain Res 303:197–200
Amaral DG, Insausti R, Campbell MJ (1988) Distribution of somatostatin immunoreactivity in the human dentate gyrus. J Neurosci 8:3306–3316
Arnold SE, Trojanowski JQ (1996) Human fetal hippocampal development. I. Cytoarchitecture, myeloarchitecture, and neuronal morphologic features. J Comp Neurol 367:274–292
Bachevalier J, Mishkin M (1994) Effects of selective neonatal temporal lobe lesions on visual recognition memory in rhesus monkeys. J Neurosci 14:2128–2139
Bachevalier J, Vargha-Khadem F (2005) The primate hippocampus: ontogeny, early insult and memory. Curr Opin Neurobiol 15:168–174
Bachevalier J, Brickson M, Hagger C (1993) Limbic-dependent recognition memory in monkeys develops early in infancy. Neuroreport 4:77–80
Bakst I, Morrison JH, Amaral DG (1985) The distribution of somatostatin-like immunoreactivity in the monkey hippocampal formation. J Comp Neurol 236:423–442
Baraban SC, Tallent MK (2004) Interneuron diversity series: interneuronal neuropeptides-endogenous regulators of neuronal excitability. Trends Neurosci 27:135–142
Binaschi A, Bregola G, Simonato M (2003) On the role of somatostatin in seizure control: clues from the hippocampus. Rev Neurosci 14:285–301
Bouras C, Magistretti PJ, Morrison JH, Constantinidis J (1987) An immunohistochemical study of pro-somatostatin-derived peptides in the human brain. Neuroscience 22:781–800
Chan-Palay V (1987) Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia. J Comp Neurol 260:201–223
Chan-Palay V, Kohler C, Haesler U, Lang W, Yasargil G (1986) Distribution of neurons and axons immunoreactive with antisera against neuropeptide Y in the normal human hippocampus. J Comp Neurol 248:360–375
Coveñas R, Aguirre JA, de Leon M, Alonso JR, Narvaez JA, Arevalo R, Gonzalez-Baron S (1990) Distribution of neuropeptide Y-like immunoreactive cell bodies and fibers in the brain stem of the cat. Brain Res Bull 25:675–683
Coveñas R, Mangas A, Medina LE, Sánchez ML, Aguilar LA, Díaz-Cabiale Z, Narváez JA (2011) Mapping of somatostatin-28 (1–12) in the alpaca diencephalon. J Chem Neuroanat 42:89–98
de Graaf-Peters VB, Hadders-Algra M (2006) Ontogeny of the human central nervous system: what is happening when? Early Hum Dev 82:257–266
de Leon M, Covenas R, Narvaez JA, Tramu G, Aguirre JA, Gonzalez-Baron S (1991) Somatostatin-28 (1–12)-like immunoreactivity in the cat diencephalon. Neuropeptides 19:107–117
Fitzpatrick-McElligott S, Card JP, O’Kane TM, Baldino F Jr (1991) Ontogeny of somatostatin mRNA-containing perikarya in the rat central nervous system. Synapse 7:123–134
Forloni G, Hohmann C, Coyle JT (1990) Developmental expression of somatostatin in mouse brain. I. Immunocytochemical studies. Brain Res Dev Brain Res 53:6–25
Freund TF, Buzsaki G (1996) Interneurons of the hippocampus. Hippocampus 6:347–470
Furtinger S, Pirker S, Czech T, Baumgartner C, Ransmayr G, Sperk G (2001) Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 21:5804–5812
Gogtay N, Nugent TF 3rd, Herman DH, Ordonez A, Greenstein D, Hayashi KM, Clasen L, Toga AW, Giedd JN, Rapoport JL, Thompson PM (2006) Dynamic mapping of normal human hippocampal development. Hippocampus 16:664–672
Gray WP (2008) Neuropeptide Y signalling on hippocampal stem cells in health and disease. Mol Cell Endocrinol 288:52–62
Guntern R, Vallet PG, Bouras C, Constantinidis J (1989) An improved immunohistostaining procedure for peptides in human brain. Experientia 45:159–161
Herlenius E, Lagercrantz H (2001) Neurotransmitters and neuromodulators during early human development. Early Hum Dev 65:21–37
Insausti R, Cebada-Sanchez S, Marcos P (2010) Postnatal development of the human hippocampal formation. Adv Anat Embryol Cell Biol 206:1–86
Iritani S, Kuroki N, Niizato K, Ikeda K (2000) Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry 24:241–249
Jinno S (2009) Structural organization of long-range GABAergic projection system of the hippocampus. Front Neuroanat 3:1–9
Jinno S, Kosaka T (2003) Patterns of expression of neuropeptides in GABAergic nonprincipal neurons in the mouse hippocampus: quantitative analysis with optical disector. J Comp Neurol 461:333–349
Jinno S, Kosaka T (2006) Cellular architecture of the mouse hippocampus: a quantitative aspect of chemically defined GABAergic neurons with stereology. Neurosci Res 56:229–245
Khazipov R, Esclapez M, Caillard O, Bernard C, Khalilov I, Tyzio R, Hirsch J, Dzhala V, Berger B, Ben-Ari Y (2001) Early development of neuronal activity in the primate hippocampus in utero. J Neurosci 21:9770–9781
Kowalski C, Micheau J, Corder R, Gaillard R, Conte-Devolx B (1992) Age-related changes in cortico-releasing factor, somatostatin, neuropeptide Y, methionine enkephalin and beta-endorphin in specific rat brain areas. Brain Res 582:38–46
Lavenex P, Banta Lavenex P, Amaral DG (2007) Postnatal development of the primate hippocampal formation. Dev Neurosci 29:179–192
Lavenex P, Lavenex PB, Bennett JL, Amaral DG (2009) Postmortem changes in the neuroanatomical characteristics of the primate brain: hippocampal formation. J Comp Neurol 512:27–51
Ledri M, Sorensen AT, Erdelyi F, Szabo G, Kokaia M (2010) Tuning afferent synapses of hippocampal interneurons by neuropeptide Y. Hippocampus 21:198–211
Levitt P (2003) Structural and functional maturation of the developing primate brain. J Pediatr 143(4 Suppl):S35–S45
Lotstra F, Schiffmann SN, Vanderhaeghen JJ (1989) Neuropeptide Y-containing neurons in the human infant hippocampus. Brain Res 478:211–226
Matyas F, Freund TF, Gulyas AI (2004) Immunocytochemically defined interneuron populations in the hippocampus of mouse strains used in transgenic technology. Hippocampus 14:460–481
Morrison JH, Benoit R, Magistretti PJ, Ling N, Bloom FE (1982) Immunohistochemical distribution of pro-somatostatin-related peptides in hippocampus. Neurosci Lett 34:137–142
Morys JM, Kowianski P, Morys J (2002) Distribution of nitric oxide synthase and neuropeptide Y neurones during the development of the hippocampal formation in the rat. Folia Morphol (Warsz) 61:221–232
Naus CC, Morrison JH, Bloom FE (1988) Development of somatostatin-containing neurons and fibers in the rat hippocampus. Brain Res 468:113–121
Pascalis O, Bachevalier J (1999) Neonatal aspiration lesions of the hippocampal formation impair visual recognition memory when assessed by paired-comparison task but not by delayed nonmatching-to-sample task. Hippocampus 9:609–616
Pascalis O, de Schonen S (1994) Recognition memory in 3- to 4-day-old human neonates. Neuroreport 5:1721–1724
Ramos B, Baglietto-Vargas D, del Rio JC, Moreno-Gonzalez I, Santa-Maria C, Jimenez S, Caballero C, Lopez-Tellez JF, Khan ZU, Ruano D, Gutierrez A, Vitorica J (2006) Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer’s disease. Neurobiol Aging 27:1658–1672
Siggins GR, French ED (1984) Pro-somatostatin related peptides alter the discharge rate of rat cortical and hippocampal neurons in vivo: an iontophoretic study. Soc Neurosci Abstr 10:810
Sperk G, Hamilton T, Colmers WF (2007) Neuropeptide Y in the dentate gyrus. Prog Brain Res 163:285–297
Tallent MK (2007) Somatostatin in the dentate gyrus. Prog Brain Res 163:265–284
Tallent MK, Qiu C (2008) Somatostatin: an endogenous antiepileptic. Mol Cell Endocrinol 286:96–103
Wilcox BJ, Unnerstall JR (1990) Identification of a subpopulation of neuropeptide Y-containing locus coeruleus neurons that project to the entorhinal cortex. Synapse 6:284–291
Acknowledgments
This research was conducted on samples from the Andalusian Public Health System Biobank (ISCIII-Red de Biobancos RD09/0076/00085). The authors are grateful to Drs. Tuñón and García-Bragado from the Navarra Department of Health, Dr. Rábano from Alcorcón Foundation Hospital, and the Pathology Service of the University Hospital in Albacete (Dr. Atiénzar) for the provision of human infant tissue and to Dr. Tramu (Université de Bordeaux I, France) for kindly providing NPY and SOM-12 antibodies. The authors also thank the technical team of the Human Neuroanatomy Laboratory of the University of Castilla-La Mancha and the technicians of the Virgen del Rocío Hospital for their crucial contribution to the preparation of the human brain tissue. Special thanks are extended to the donors and their families.
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the NINDS (grant 2R01NS016980) and the Junta de Comunidades de Castilla-La Mancha, Spain (grants PC108-0113 and PI-2006/14).
Rights and permissions
About this article
Cite this article
Cebada-Sánchez, S., Insausti, R., González-Fuentes, J. et al. Distribution of peptidergic populations in the human dentate gyrus (Somatostatin [SOM-28, SOM-12] and Neuropeptide Y [NPY]) during postnatal development. Cell Tissue Res 358, 25–41 (2014). https://doi.org/10.1007/s00441-014-1929-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-014-1929-2